# Influence of Gut Microbiota on the Development of Type 2 Diabetes Mellitus and Personalization of Diabetes-lowing Therapy

> **NCT07627048** · — · COMPLETED · sponsor: **Pirogov Russian National Research Medical University** · enrollment: 100 (actual)

## Conditions studied

- Type 2 Diabetes (T2DM)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07627048
- **Lead sponsor:** Pirogov Russian National Research Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-04-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07627048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07627048, "Influence of Gut Microbiota on the Development of Type 2 Diabetes Mellitus and Personalization of Diabetes-lowing Therapy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07627048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*